- Report
- February 2024
- 442 Pages
Global
From €5317EUR$5,500USD£4,570GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2023
- 315 Pages
Global
From €4639EUR$4,799USD£3,988GBP
- Report
- May 2022
- 61 Pages
Global
- Report
- November 2021
- 156 Pages
Global
From €6719EUR$6,950USD£5,775GBP
- Report
- January 2021
Global
From €3079EUR$3,185USD£2,646GBP
€4399EUR$4,550USD£3,781GBP
- Report
- April 2021
- 47 Pages
Global
€21268EUR$22,000USD£18,280GBP
- Report
- March 2021
- 52 Pages
Global
€1274EUR$1,318USD£1,095GBP
- Report
- January 2019
- 717 Pages
Global
From €21268EUR$22,000USD£18,280GBP
- Report
- June 2020
- 155 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- June 2020
- 69 Pages
Asia Pacific
From €1450EUR$1,500USD£1,246GBP
From €115EUR$119USD£99GBP
- Report
- January 2023
- 221 Pages
Global
From €5539EUR$5,730USD£4,761GBP
Macrophages are a type of white blood cell that play a key role in the body's immune system. They are responsible for recognizing, engulfing, and destroying foreign particles, such as bacteria and viruses. In biotechnology, macrophages are used to study the immune system and develop treatments for diseases. They are also used in the development of vaccines, gene therapy, and cancer treatments.
Macrophages are also used in regenerative medicine, where they are used to repair damaged tissue and organs. They are also used in the development of stem cell therapies, which are used to treat a variety of diseases.
In the biotechnology market, macrophages are used in a variety of ways, from research and development to clinical applications. Companies in the macrophage market include AbbVie, AstraZeneca, Celgene, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
